"In my lifetime, I’ve never seen the extent of collaboration that’s happening within the life sciences industry."
COVID-19 has already had a huge impact on life sciences, with organisations working together on vaccine discovery and sharing manufacturing facilities.
In this video I highlight four areas that could be part of the new reality for life sciences as we emerge from COVID-19: Virtual operations, More emphasis on national supply, Virtual drug discovery, and Enterprise risk management.